{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:21:29Z","timestamp":1787757689603,"version":"build-2784847793"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Intraocular infection in patients with COVID-19 could be different in the presence of treatment with systemic corticosteroid and immunosuppressive agents. We describe the epidemiology and microbiological profile of intraocular infection in COVID-19 patients after their release from the hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We analyzed the clinical and microbiological data of laboratory-confirmed COVID-19 patients from April 2020 to January 2021 presenting with features of endogenous endophthalmitis within 12 weeks of their discharge from the hospital in two neighboring states in South India. The data included demography, systemic comorbidities, COVID-19 treatment details, time interval to visual symptoms, the microbiology of systemic and ocular findings, ophthalmic management, and outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mean age of 24 patients (33 eyes) was 53.6 \u00b1 13.5 (range: 5\u201372) years; 17 (70.83%) patients were male. Twenty-two (91.6%) patients had systemic comorbidities, and the median period of hospitalization for COVID-19 treatment was 14.5 \u00b1 0.7 (range: 7\u201363) days. Infection was bilateral in nine patients. COVID-19 treatment included broad-spectrum systemic antibiotics (all), antiviral drugs (22, 91.66% of patients), systemic corticosteroid (21, 87.5% of patients), supplemental oxygen (18, 75% of patients), low molecular weight heparin (17, 70.8% of patients), admission in intensive care units (16, 66.6% of patients), and interleukin-6 inhibitor (tocilizumab) (14, 58.3% of patients). Five (20.8%) patients died of COVID-19-related complications during treatment for endophthalmitis; one eye progressed to pan ophthalmitis and orbital cellulitis; eight eyes regained vision &gt;20\/400. Fourteen of 19 (73.7%) vitreous biopsies were microbiologically positive (culture, PCR, and microscopy), and the majority (11 patients, 78.5%) were fungi.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Intraocular infection in COVID-19 patients is predominantly caused by fungi. We suggest a routine eye examination be included as a standard of care of COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_1474_21","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T06:54:59Z","timestamp":1638255299000},"page":"3664-3676","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Sight-threatening intraocular infection in patients with COVID-19 in India"],"prefix":"10.4103","volume":"69","author":[{"given":"Sameera","family":"Nayak","sequence":"first","affiliation":[{"name":"Vitreo-Retina and Uvea Services, L V Prasad Eye Institute, Kode Venkatadri Chowdary Campus, Vijayawada, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taraprasad","family":"Das","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Parameswarappa","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitri","family":"Sharma","sequence":"additional","affiliation":[{"name":"Jhaveri Microbiology Centre and Saroja A Rao Immunology Laboratory, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumya","family":"Jakati","sequence":"additional","affiliation":[{"name":"Ophthalmic Pathology Laboratory, L V Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhadra","family":"Jalali","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyava","family":"Basu","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudit","family":"Tyagi","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek Pravin","family":"Dave","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev Reddy","family":"Pappuru","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Pathengay","sequence":"additional","affiliation":[{"name":"Uvea Services, L V Prasad Eye Institute, GMR Varalakshmi Campus, Vishakhapatnam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hrishikesh","family":"Kaza","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmaja Kumari","family":"Rani","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashwat","family":"Behera","sequence":"additional","affiliation":[{"name":"Vitreo-Retina and Uvea Services, L V Prasad Eye Institute, Kode Venkatadri Chowdary Campus, Vijayawada, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroj Kumar","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Vitreo-Retina and Uvea Services, L V Prasad Eye Institute, Kode Venkatadri Chowdary Campus, Vijayawada, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Vitreo-Retina and Uvea Services, L V Prasad Eye Institute, Kode Venkatadri Chowdary Campus, Vijayawada, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitesh","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Takkar","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Ramesh","family":"Raval","sequence":"additional","affiliation":[{"name":"Smt. Kanuri Santhamma Centre for Vitreo-Retinal Diseases, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: A systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J Infect"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jinf.2020.08.005","article-title":"COVID-19 associated invasive candidiasis","volume":"82","author":"Al-Hatmi","year":"2021","journal-title":"J Infect"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1016\/S2666-5247(20)30027-6","article-title":"Diagnosing COVID-19-associated pulmonary aspergillosis","volume":"1","author":"Verweij","year":"2020","journal-title":"Lancet Microbe"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"e00867","DOI":"10.1016\/j.idcr.2020.e00867","article-title":"Unique case of central retinal artery occlusion secondary to COVID-19 disease","volume":"21","author":"Acharya","year":"2020","journal-title":"IDCases"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0140-6736(20)31014-X","article-title":"Retinal findings in patients with COVID-19","volume":"395","author":"Marinho","year":"2020","journal-title":"Lancet"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09273948.2020.1738501","article-title":"Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals","volume":"28","author":"Seah","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4103\/ijo.IJO_2380_20","article-title":"Retinal vein occlusion in COVID-19: A novel entity","volume":"68","author":"Sheth","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","article-title":"Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China","volume":"138","author":"Wu","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/WNO.0000000000001039","article-title":"Severe bilateral vision loss in 2 patients with coronavirus disease 2019","volume":"40","author":"Cyr","year":"2020","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"key":"B13-20240828","first-page":"e1056","article-title":"Episcleritis as an ocular manifestation in a patient with COVID-19","volume":"98","author":"Mangana","year":"2020","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.4103\/ijo.IJO_1319_20","article-title":"Clinical profile and prevalence of conjunctivitis in mild COVID-19 patients in a tertiary care COVID-19 hospital: A retrospective cross-sectional study","volume":"68","author":"Sindhuja","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/ijo.IJO_297_21","article-title":"COVID-19 and eye: A review of ophthalmic manifestations of COVID-19","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/IAE.0000000000003168","article-title":"Endogenous endophthalmitis in the setting of Covid-19 infection: A case series","volume":"41","author":"Bilgic","year":"2021","journal-title":"Retina"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4103\/ijo.IJO_3755_20","article-title":"A case series of presumed fungal endogenous endophthalmitis in post COVID-19 patients","volume":"69","author":"Shah","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4103\/ijo.IJO_403_21","article-title":"Retinal manifestations in patients following COVID-19 infection: A consecutive case series","volume":"69","author":"Goyal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B20-20240828","article-title":"Case control analyses of acute endophthalmitis after cataract surgery in south india associated with technique, patient care, and socioeconomic status","author":"Das","year":"2012","journal-title":"J Ophthalmol 2012"},{"key":"B21-20240828","first-page":"1479","article-title":"Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group","volume":"113","year":"1995","journal-title":"Arch Ophthalmol Chic Ill 1960"},{"key":"B22-20240828","doi-asserted-by":"crossref","first-page":"xx","DOI":"10.1016\/j.ajo.2017.11.021","article-title":"Endophthalmitis: Then and now","volume":"187","author":"Relhan","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B23-20240828","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/08820538.2017.1416411","article-title":"Endophthalmitis progressing to panophthalmitis: Clinical features, demographic profile, and factors predicting outcome","volume":"33","author":"Pappuru","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"B24-20240828","first-page":"491","article-title":"Endogenous endophthalmitis","volume":"26","author":"Cunningham","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"B25-20240828","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"B26-20240828","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"B28-20240828","doi-asserted-by":"crossref","first-page":"fiz187","DOI":"10.1093\/femsec\/fiz187","article-title":"Antibiotic-induced gut metabolome and microbiome alterations increase the susceptibility to Candida albicans colonization in the gastrointestinal tract","volume":"96","author":"Gutierrez","year":"2020","journal-title":"FEMS Microbiol Ecol"},{"key":"B29-20240828","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1179\/joc.1999.11.5.385","article-title":"Documented fungal infections after prophylaxis or therapy with wide spectrum antibiotics: Relationship between certain fungal pathogens and particular antimicrobials?","volume":"11","author":"Krcm\u00e9ry","year":"1999","journal-title":"J Chemother Florence Italy"},{"key":"B30-20240828","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1084\/jem.183.4.1345","article-title":"Impaired neutrophil response and CD4+T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans","volume":"183","author":"Romani","year":"1996","journal-title":"J Exp Med"},{"key":"B31-20240828","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/annrheumdis-2018-214367","article-title":"Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: A multidatabase cohort study","volume":"78","author":"Pawar","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B32-20240828","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijid.2020.07.036","article-title":"Appropriate use of tocilizumab in COVID-19 infection","volume":"99","author":"Keske","year":"2020","journal-title":"Int J Infect Dis"},{"key":"B33-20240828","doi-asserted-by":"crossref","first-page":"102564","DOI":"10.1016\/j.autrev.2020.102564","article-title":"Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: An increased risk for candidemia?","volume":"19","author":"Antinori","year":"2020","journal-title":"Autoimmun Rev"},{"key":"B34-20240828","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.riam.2020.07.001","article-title":"Fungal co-infection in COVID-19 patients: Should we be concerned?","volume":"37","author":"Pem\u00e1n","year":"2020","journal-title":"Rev Iberoam Micol"},{"key":"B35-20240828","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1517\/17425247.2011.628983","article-title":"Strategies for therapy of retinal diseases using systemic drug delivery: Relevance of transporters at the blood-retinal barrier","volume":"8","author":"Hosoya","year":"2011","journal-title":"Expert Opin Drug Deliv"},{"key":"B36-20240828","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: Biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fern\u00e1ndez","year":"2020","journal-title":"Pharmaceutics"},{"key":"B37-20240828","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4103\/ijo.IJO_1091_19","article-title":"Clinical presentations, microbiology and management outcomes of culture-proven endogenous endophthalmitis in India","volume":"68","author":"Dave","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"B38-20240828","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-018-0158-3","article-title":"Endogenous endophthalmitis: A 9-year retrospective study at a tertiary referral hospital in Malaysia","volume":"8","author":"Muda","year":"2018","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"B39-20240828","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/APO.0000000000000120","article-title":"Endogenous endophthalmitis: A 10-year retrospective study at a tertiary hospital in South India","volume":"4","author":"Ratra","year":"2015","journal-title":"Asia-Pac J Ophthalmol Phila Pa"},{"key":"B40-20240828","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00005792-200303000-00004","article-title":"Endogenous endophthalmitis: An 18-year review of culture-positive cases at a tertiary care center","volume":"82","author":"Binder","year":"2003","journal-title":"Medicine (Baltimore)"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1474_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:47:22Z","timestamp":1787755642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1474_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1474_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"assertion":[{"value":"2021-05-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}